GALAPAGOS
LIVE

Serial Number

88110392

Owner

Galapagos N.V.

Attorney

Alexandra MacKay

Filing Date

Sep 10, 2018

Add to watchlist:

No watchlists yet
View on USPTO

GALAPAGOS Trademark

Serial Number: 88110392 • Registration: 5888518

GALAPAGOS is a trademark filed by Galapagos N.V. on September 10, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Galapagos N.V. (6 trademarks)

Generaal de Wittelaan L11 A3
Mechelen BE-2800 , BE

Entity Type: 03

Trademark Details

Filing Date

September 10, 2018

Registration Date

October 22, 2019

Published for Opposition

August 6, 2019

Goods & Services

[ medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate same via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; and gene bank services for research purposes ]

pharmaceutical substances and preparations for human use, namely, for the treatment of [ bone cartilage and joint disease, ] autoinflammation diseases, autoimmune diseases, proliferative diseases, [ endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, ] lupus [ , uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes ] ; biopharmaceutical substances and preparations for human use, namely, for the treatment of [ bone cartilage and joint disease, ] autoinflammation diseases, autoimmune diseases, proliferative diseases, [ endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, ] lupus [ , uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes ]

[ medical services; medical and pharmaceutical advisory and consultancy services; gene bank services ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Feb 24, 2026 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Feb 24, 2026 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2026 APRE
TEAS SECTION 8 RECEIVED
Oct 6, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 22, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2019 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Jul 2, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jun 28, 2019 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2019 CRFA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 5, 2019 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2018 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 22, 2018 AMPX
ASSIGNED TO LIE
Oct 18, 2018 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 9, 2018 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2018 NWOS
NEW APPLICATION ENTERED
Sep 13, 2018 NWAP